Review raises concerns about women's libido drug flibanserin [GsU4NpLp-u0]

Review raises concerns about women's libido drug flibanserin [GsU4NpLp-u0]

| 1h 28m 28s | Video has closed captioning.

There are new concerns about the safety of the only female libido drug approved by the FDA. Flibanserin, sold under the brand name Addyi, was approved last summer. Supporters called it a victory for women suffering from lower sexual desire, but a review in a medical journal questions the quality of the drug. Dr. Tara Narula joins “CBS This Morning” to discuss the findings.